US Stock MarketDetailed Quotes
JAZZ Jazz Pharmaceuticals
- 125.070
- +5.830+4.89%
Trading Nov 21 15:54 ET
7.56BMarket Cap17.72P/E (TTM)
125.640High120.070Low755.47KVolume121.840Open119.240Pre Close93.35MTurnover1.29%Turnover Ratio20.50P/E (Static)60.45MShares134.17052wk High1.81P/B7.34BFloat Cap99.06052wk Low--Dividend TTM58.67MShs Float194.730Historical High--Div YieldTTM4.67%Amplitude0.515Historical Low123.565Avg Price1Lot Size
About Jazz Pharmaceuticals Company
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.
Company Profile
SymbolJAZZ
Company NameJazz Pharmaceuticals
Listing DateJun 1, 2007
Issue Price18.00
Founded2005
CEOMr. Bruce C. Cozadd
MarketNASDAQ
Employees2800
Fiscal Year Ends12-31
AddressWaterloo Exchange,Waterloo Road,5th Floor
CityDublin
ProvinceDublin
CountryIreland
Zip Code4
Phone353-1-634-7800
Company Executives
- Name
- Position
- Salary
- Bruce C. Cozadd
- Chairman of the Board and Chief Executive Officer
- 15.34M
- Renee D. Gala
- President and Chief Operating Officer
- 5.43M
- Neena M. Patil
- Executive Vice President and Chief Legal Officer
- 3.88M
- Patricia Carr
- Senior Vice President and Chief Accounting Officer
- 1.40M
- Philip L. Johnson
- Executive Vice President and Chief Financial Officer
- --
- Dr. Robert Iannone, M.D.
- Executive Vice President and Global Head of Research and Development
- 4.98M
- Samantha Pearce
- Senior Vice President, Europe and International
- --
- Liz Henderson
- Senior Vice President, Technical Operations
- --
- Patrick Thomas Kennedy
- Independent Director
- --
- Dr. Mark D. Smith, M.D.
- Independent Director
- 521.27K
- Jennifer E. Cook
- Independent Director
- 533.77K
- Seamus C. Mulligan
- Independent Director
- 531.27K
- Laura J. Hamill
- Independent Director
- --
- Heather Ann McSharry
- Independent Director
- 543.77K
- Anne O'Riordan
- Independent Director
- 523.77K
- Kenneth W. O'Keefe
- Independent Director
- 513.77K
- Patrick G. Enright
- Independent Director
- 526.27K
- Rick E. Winningham
- Lead Independent Director
- 571.27K
- Dr. Norbert G. Riedel,PhD
- Independent Director
- 533.77K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data